欧洲跨学科指南:皮肤侵袭性鳞状细胞癌(第一部分:流行病学、诊断与预防)
该指南由欧洲皮肤病论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症研究与治疗组织(EORTC)的多学科专家合作制定,基于当前文献、分期系统和专家共识,更新了皮肤侵袭性鳞状细胞癌(cSCC)的分类、诊断、风险分层、分期和预防建议。常见cSCC通常为惰性肿瘤,多数预后良好,5年治愈率超过90%,转移率低于4%。建议根据提出的高危因素将常见原发性cSCC进一步风险分层为低危或高危,并对高危cSCC进行影像学分期。
要点
- 所有cSCC应进行全身皮肤检查和淋巴结临床触诊,尤其是引流区。
- 高危cSCC推荐行区域淋巴结超声、MRI、CT或PET-CT等影像学分期。
- 目前不推荐前哨淋巴结活检;化学预防药物非常规推荐。
核心结论
- 常见cSCC多为惰性肿瘤,5年治愈率超过90%,转移率低于4%。
- 建议将常见原发性cSCC按高危因素分为低危和高危以指导管理。
- 晚期cSCC分为局部晚期(lacSCC)和转移性(mcSCC),后者包括区域淋巴结转移或远处转移。
研究设计与样本
- 由EDF、EADO和EORTC多学科专家合作制定,基于当前文献、分期系统和专家共识更新推荐。
主要发现
- cSCC在白种人群中占所有皮肤恶性肿瘤的20%。
- cSCC病因相关因素包括紫外线暴露和慢性光老化、年龄、男性、免疫抑制、吸烟和遗传因素。
- 常见cSCC 5年治愈率大于90%,转移率低于4%。
关键数值与推荐
- 推荐对所有cSCC进行全身皮肤检查和淋巴结临床触诊,尤其是引流区。
- 推荐高危cSCC采用区域淋巴结超声、MRI、CT或PET-CT进行分期。
- 目前不推荐前哨淋巴结活检。
- 烟酰胺、口服维A酸类和局部5-FU曾用于高危患者后续cSCC的化学预防,但非常规推荐。
- 推荐防晒教育,包括减少日晒、使用防护衣物、定期使用防晒霜和避免人工晒黑。
临床怎么用
- 临床应依据高危因素对常见原发性cSCC进行低危/高危分层。
- 对所有cSCC患者进行全身皮肤检查及引流区淋巴结触诊。
- 对高危cSCC患者合理选用超声、MRI、CT或PET-CT进行分期。
- 不常规推荐前哨淋巴结活检和化学预防药物,应强化防晒教育。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (<4%). Further risk stratification into low-risk or high-risk common primary cSCC is recommended based on proposed high-risk factors. Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) including locoregional metastatic or distant metastatic cSCC. Current systems used for staging include the American Joint Committee on Cancer (AJCC) 8th edition, the Union for International Cancer Control (UICC) 8th edition, and Brigham and Women's Hospital (BWH) system. Physical examination for all cSCCs should include total body skin examination and clinical palpation of lymph nodes, especially of the draining basins. Radiologic imaging such as ultrasound of the regional lymph nodes, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT) scans are recommended for staging of high-risk cSCC. Sentinel lymph node biopsy is currently not recommended. Nicotinamide, oral retinoids, and topical 5-FU have been used for the chemoprevention of subsequent cSCCs in high-risk patients but are not routinely recommended. Education about sun protection measures including reducing sun exposure, use of protective clothing, regular use of sunscreens and avoidance of artificial tanning, is recommended.
引用
- Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer. 2020. PMID: 32113941. doi:10.1016/j.ejca.2020.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。